Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Portable Temperature Control

July 26, 2010 8:05 am | Product Releases | Comments

The TG40 System from Centeo Biosciences Ltd. enables rapid screening of experimental temperature conditions from 4ºC to 60ºC and portable temperature control maintains set temperature during analysis.


Sequencing Kit

July 26, 2010 8:00 am | Product Releases | Comments

Illumina, Inc. has launched the TruSeq SBS Sequencing kit, which will enable high-quality paired end reads of 150 base pairs, increase the output of high-quality base calls, and enhance throughput to greater than 95 Gigabases per run on Illumina's Genome Analyzer sequencing system.


Thermo Establishing Tokyo Biomarker Research Center

July 26, 2010 7:50 am | News | Comments

The collaboration between Thermo Fisher's Biomarker Research Initiatives in Mass Spectrometry (BRIMS) Center and the Tokyo Medical University Hospital means to establish and support a new Biomarker Research Center in Tokyo, Japan to focus on biomarker discovery and quantification.


FTC Accuses Watson of Obstructing Investigation

July 26, 2010 7:44 am | News | Comments

The Federal Trade Commission has accused Watson Pharmaceuticals Inc. of delaying an investigation into a potential "pay-for-delay" deal on a generic sleep disorder drug.


Many Genetic Variations Responsible for HTG

July 26, 2010 7:36 am | News | Comments

It can make blood look like cream of tomato soup. Patients with high levels of triglycerides in their blood, a disease called hypertriglyceridemia face an increased risk for heart disease and stroke.


Key Enzyme Reverses Sun Damage

July 26, 2010 7:26 am | News | Comments

For the first time, researchers have witnessed how the enzyme photolyase works at the atomic level to repair sun-damaged DNA.


FDA Approves Generic Lovenox

July 26, 2010 7:09 am | News | Comments

Biotechnology company Momenta Pharmaceuticals Inc. said the U.S. Food and Drug Administration approved its generic version of Sanofi-Aventis SA's Lovenox, an injected drug for preventing life-threatening blood clots.


All-Clear for Larger Aricept Dose

July 26, 2010 7:07 am | News | Comments

Drugmakers Eisai Inc. and Pfizer Inc. said that government regulators have given them permission to make a larger dose of its Alzheimer's disease drug Aricept for patients who have already been taking the smaller dose.


FDA Panel Wants Tougher Painkiller Restrictions

July 26, 2010 7:01 am | News | Comments

Federal health advisers said a government proposal to curb misuse of powerful painkillers does not go far enough to fix a problem linked to hundreds of fatal overdoses annually.


Sanofi May Buy Genzyme

July 26, 2010 6:57 am | News | Comments

Shares of Genzyme Corp. soared after a report was published that French pharmaceutical company Sanofi-Aventis is interested in the biotechnology drugmaker.


Web-Based LIMS Viewer

July 23, 2010 7:59 am | Product Releases | Comments

Labtronics Inc., a leader in laboratory automation has released a web based viewer for LimsLink, it's industry leading laboratory integration solution.


Custom Genotyping Array

July 23, 2010 7:56 am | Product Releases | Comments

Affymetrix, Inc. announced that it has launched Axiom Custom Genotyping Arrays, the newest addition to the Axiom Genotyping Solution. Researchers can now leverage Affymetrix’ Axiom Genomic Database to create custom arrays.


ChanTest Hires New Head of GCPR And HTS Services

July 23, 2010 7:36 am | News | Comments

Emir Duzic, PhD has joined ChanTest Corporation as head of GPCR and HTS Assay Services. Dr. Duzic has overall responsibility for developing, optimizing, standardizing and running all GPCR assays for customer compounds and all GPCR research projects.


Baxter Income Slips 9% for Q2

July 23, 2010 7:30 am | News | Comments

Drug and medical device maker Baxter International Inc. said its net income fell 9 percent in the second quarter because of higher costs and a settlement with the government of Greece.


Researchers Create In Silico Model of IBS

July 23, 2010 7:24 am | News | Comments

Scientists at the Virginia Bioinformatics Institute have constructed a mathematical and computational model of inflammatory bowel disease that allows researchers to simulate the cellular and molecular changes underlying chronic inflammation in humans.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.